ROR-gamma t inverse agonists (Advinus Therapeutics)

N/A

Report date: 2025/01/26 17:10:15
NME

Base Information

Drug NameROR-gamma t inverse agonists (Advinus Therapeutics)
Drug Alias NameRO-2 (Advinus Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma inverse agonistsInterleukin 17A inhibitors
TargetsNuclear receptor ROR-gammaInterleukin 17A
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEurofins Advinus Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A